Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score for Predicting Prognosis of Hepatocellular Carcinoma Patients Undergoing Conventional Transarterial Chemoembolization
The baseline mALF score was useful in stratifying HCC patients undergoing cTACE, according to post-treatment prognosis. Increased mALF scores after cTACE were associated with poor prognosis in patients with a baseline mALF score of 0 or 1. Assessment of baseline and post-treatment mALF scores may help in predicting prognosis in HCC patients following cTACE.
Authors
- Manabu Hayashi (ORCID: https://orcid.org/0000-0002-2213-3918)
- Masashi Fujita (ORCID: https://orcid.org/0000-0002-1457-6233)
- Yosuke Takahata
- Tatsuro Sugaya (ORCID: https://orcid.org/0000-0002-8703-6078)
- Kazumichi Abe (ORCID: https://orcid.org/0000-0001-5359-9465)
- Hiromasa Ohira (ORCID: https://orcid.org/0000-0003-4331-0634)
- Naoto Abe
Institutions
- Fukushima Medical University (JP)
Publication Details
- Journal
- Oncology
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1159/000546334
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00